From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
 | Total |
---|---|
 | n = 194 |
Age at time of PET/CT (years), median (IQR) | 70.0 (63.0–75.0) |
Most recent PSA prior to PET/CT (ng/mL), median (IQR) | 10.0 (6.5–18.0) |
PSA groups (ng/mL) (n = 194) |  |
  ≤10 | 101 (52.1%) |
10 –20 | 50 (25.8%) |
 > 20 | 43 (22.2%) |
ISUP grade (n = 189) |  |
1 | 8 (4.2%) |
2 | 41 (21.7%) |
3 | 50 (26.5%) |
4 | 34 (18.0%) |
5 | 56 (29.6%) |
Previous/current ADT prior to the PET/CT scan | 14 (7.2%) |
Duration of ADT prior to PET/CT scan (months), median (IQR) (n = 14) | 2.0 (2.0–5.0) |